Of broken elevators and bonds: Staying connected to those we’ve lost to ALS

A global group of experts is recommending that all individuals worldwide who are diagnosed with amyotrophic lateral sclerosis (ALS) be offered genetic testing alongside appropriate counseling and support. The team, convened by the International Alliance of ALS/MND Associations, issued “global best practice recommendations” for ALS in a newly published…

Some people with ALS take a long time to get diagnosed, but in my husband’s case, I’ve often felt like the diagnosis came too quickly. Since there was no treatment that could have significantly altered the course of Todd’s disease, and since he ended up having a slow-progressing…

QRL-201, an experimental therapy from Quralis, slowed disease progression by 50% in people with amyotrophic lateral sclerosis (ALS) who received one of the tested doses of the therapy, according to final results from a Phase 1/2 clinical trial. The findings come from the dose-range finding phase of the…

Precision Neuroscience and the nonprofit Team Gleason are partnering to give people with amyotrophic lateral sclerosis (ALS), their families, and caregivers a direct role in shaping a brain-computer interface (BCI). Precision is developing the BCI system for people with severe paralysis caused by conditions including ALS and…

Elevated blood levels of neurofilament light chain (NfL), a protein released when nerve cells are damaged, are associated with an increased risk of developing amyotrophic lateral sclerosis (ALS), potentially years before symptoms emerge, according to a new study. The analysis, which included more than 52,000 people in the U.K.,…

After showing encouraging early signs of disease stabilization and functional improvements in a small study, an experimental infusion therapy for amyotrophic lateral sclerosis (ALS) is advancing to a new, larger clinical trial in Australia. Nuerve announced in a company press release…

The recent Muscular Dystrophy Association (MDA) Engage Community Seminar with Stanford Medicine was packed with educational sessions, but some of the most meaningful takeaways for participants were about connection and community. “That’s what makes MDA Engage Symposium so special,” Marissa Lozano, director of community education at the MDA,…

PRC-Saltillo and Team Gleason are partnering to help people with amyotrophic lateral sclerosis (ALS) maintain communication and connections with family, friends, and their communities as the disease progresses. Under the collaboration, PRC-Saltillo will contribute its expertise in speech-generating technology and augmentative and alternative communication (AAC), while Team…

I asked our smart speaker to play music by the Lumineers while I got my husband, Todd, washed up and out of bed this morning. One of their songs, “Nobody Knows,” played, and it resonated with me and our ALS journey. “Nobody knows how to say goodbye/…